---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032620"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2026-10-14T20:05:14+00:00"
generated_at: "2026-10-14T20:06:04.008419+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CervoMed posts investor presentation to website; no clinical or financial data in 8-K text

## Summary
- CervoMed Inc. (NASDAQ: CRVO) made an investor presentation available on www.cervomed.com under 'Investors - Events and Presentations' as of October 14, 2026.
- The 8-K states the deck covers business, clinical studies, development plans and financial position, but no specific trial results, figures or guidance are included.
- Management may use the presentation periodically in conferences, meetings and presentations to investors and analysts, with possible non-material modifications.
- Signed by William Elder, Chief Financial Officer & General Counsel; the only exhibit listed is the cover page XBRL data file.
- No substantive news: the filing text contains no numbers, trial endpoints, dates or updated guidance investors can act on.

## SEC filing metadata
- accession: 0001437749-26-032620
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2026-10-14T20:05:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774926032620/0001437749-26-032620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774926032620/crvo20261014_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032620
- JSON: https://secwatch.observer/filing/0001437749-26-032620.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032620.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.